Comparing 25-gauze ProCore needles and 20-gauze ProCore needles for sampling of solid pancreatic masses

A prospective, randomized trial comparing 25-gauze ProCore needles and 20-gauze ProCore needles with coiled sheath for endoscopic ultrasound-guided sampling of solid pancreatic masses

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002485

Enrollment

Registered

2017-09-29

Start date

2016-08-31

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : EUS(endoscopic ultrasound)-guided sampling of solid pancreatic massess was done using 20-guaze or 25-guagze ProCore needles. We found the lesion using conventional linear endoscopic

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Pancreatic solid mass lesion seen on abdominal CT, MRI and ultrasonography ? lesion size : diameter =1 cm ? Patients who agree with this clinical study ? age more than 19 years

Exclusion criteria

Exclusion criteria: ? Coagulopathy (platelet< 50,000, PT(INR) >1.8) ? Mainly cystic lesion ? Patients who don't agree with this clinical study ? Patients using antiplatelets ? Patients using anticoagulants ? Patients unable to aspiration because of vascular Intervening

Design outcomes

Primary

Measure	Time frame
EUS finding(size, location, cystic component, echogenicity);symptom, past history, anticoagulant;lab finding;radiologic finding;diagnosis before histologic diagnosis;Sufficiency of tissue core for histologic diagnosis	—

Secondary

Measure	Time frame
adequacy of specimen sampling;the number of needle penetration for acquiring adequate specimen;technical failure;complication(hemorrhage, perforation, hyptension)	—

Countries

Korea, Republic of

Contacts

Public ContactChang Hwan Park

Chonnam National University

p1052ccy@hanmail.net+82-62-220-6215

Outcome results